ASML vs EPAM

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

EPAM presents a classic value trap profile: fundamentally sound but technically broken. With a Piotroski F-Score of 4/9 (Stable) and a negligible Debt/Equity ratio of 0.04, the company is financially healthy, yet the stock is in a severe multi-year downtrend (-74.1% over 5 years). While the current price of $118.98 sits comfortably below the growth-based intrinsic value of $146.83 and offers an attractive PEG ratio of 0.71, the combination of bearish insider activity and a 0/100 technical trend suggests a lack of immediate catalysts for recovery.